Patients with immunological diseases or on peritoneal dialysis are prone to false positive flow cytometry crossmatch.
暂无分享,去创建一个
A. House | L. Gunaratnam | A. Jevnikar | P. Luke | Qingyong Xu | S. Leckie
[1] K. Tinckam,et al. Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff. , 2019, Hepatobiliary surgery and nutrition.
[2] J. Friedewald,et al. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] N. K. Brown,et al. Reanalysis of the role of pronase treatment of B cells in the flow cytometric crossmatch assay: Fc receptor is not the primary target. , 2017, Human immunology.
[4] R. Bray,et al. Becoming a chef in the human leukocyte antigen kitchen: interpretation and modification of human leukocyte antigen–antibody assays , 2017, Current opinion in organ transplantation.
[5] R. Bray,et al. It's about time: The development and validation of a rapid optimized single antigen bead (ROB) assay protocol for LABScreen. , 2017, Human immunology.
[6] K. Barrios,et al. Flow cytometry crossmatch reactivity with pronase-treated T cells induced by non-HLA autoantibodies in human immunodeficiency virus-infected patients. , 2016, Human immunology.
[7] P. Nickerson,et al. cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] L. Rostaing,et al. Interference of therapeutic antibodies used in desensitization protocols on lymphocytotoxicity crossmatch results. , 2015, Transplant immunology.
[9] B. Julian,et al. New Insights into the Pathogenesis of IgA Nephropathy , 2015, Kidney Diseases.
[10] C. Lutz,et al. Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report. , 2015, Transplantation proceedings.
[11] H. Hara,et al. Acidic stress-ER stress axis for blunted activation of NF-κB in mesothelial cells exposed to peritoneal dialysis fluid. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] Dong-feng Chen,et al. Pronase Treatment Interfering with T Cell Crossmatch: 2403 , 2012 .
[13] P. Nickerson,et al. 30-OR: CANADA-WIDE EVALUATION OF RAPID OPTIMIZED FLOW CROSSMATCH (ROFCXM) PROTOCOL , 2012 .
[14] B. Julian,et al. The pathophysiology of IgA nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[15] A. Ender,et al. HLA Antibody Specification Using Single-Antigen Beads—A Technical Solution for the Prozone Effect , 2011, Transplantation.
[16] A. Zachary,et al. Impact of pronase on flow cytometric crossmatch outcome. , 2011, Human immunology.
[17] F. Meloni,et al. Effects of different peritoneal dialysis fluids on the TH1/TH2 balance. , 2011, European cytokine network.
[18] D. Heinrichs,et al. Receptor-Interacting Protein-2 Deficiency Delays Macrophage Migration and Increases Intracellular Infection during Peritoneal Dialysis-Associated Peritonitis , 2008, American Journal of Nephrology.
[19] B. Wagner,et al. Elevated B-cell autoantibodies among HIV+ transplant candidates: crossmatch implications. , 2005, Transplantation proceedings.
[20] M. Pescovitz,et al. New crossmatch technique eliminates interference by humanized and chimeric monoclonal antibodies. , 2005, Transplantation proceedings.
[21] P. Nickerson,et al. Pre‐Transplant Assessment of Donor‐Reactive, HLA‐Specific Antibodies in Renal Transplantation: Contraindication vs. Risk , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] A. Puig-Kröger,et al. Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte‐derived dendritic cells: effect of lactate and glucose‐degradation products , 2003, Journal of leukocyte biology.
[23] P. Nickerson,et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. , 2001, Journal of the American Society of Nephrology : JASN.
[24] R. Bray,et al. IMPROVED FLOW CYTOMETRIC DETECTION OF HLA ALLOANTIBODIES USING PRONASE: Potential Implications in Renal Transplantation , 2001, Transplantation.
[25] M. Girndt,et al. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[26] S. Cohen,et al. The frequency of Th2 type cells increases with time on peritoneal dialysis in patients with diabetic nephropathy. , 1999, European cytokine network.
[27] T. Pruett,et al. The use of pronase‐digested human leukocytes to improve specificity of the flow cytometric crossmatch , 1995 .
[28] L. Lebeck,et al. The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities. , 1989, Transplantation.
[29] P. Terasaki,et al. Significance of the positive crossmatch test in kidney transplantation. , 1969, The New England journal of medicine.
[30] H. Gebel,et al. Of Cells and Microparticles: Assets and Liabilities of HLA Antibody Detection. , 2018, Transplantation.
[31] M. H. Park,et al. Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests. , 2012, Transplantation proceedings.
[32] J. Friedewald,et al. Perception Versus Reality?: Virtual Crossmatch—How to Overcome Some of the Technical and Logistic Limitations , 2009 .